Francesco Alesiani

The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type‐2

Maria Beatrice Morelli, Massimo Offidani, Francesco Alesiani et al. · International Journal of Cancer · 2013 · 100 citations · Full text

Cannabis Use, Molecular Pharmacology, Hematological Malignancy +13

Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study.

Massimo Offidani, Laura Corvatta, Monica Marconi et al. · PubMed · 2006 · 78 citations

Immunology, Pathology, Pharmacotherapy +16

Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA

Attilio Olivieri, Guido Gini, Caterina Bocci et al. · The Oncologist · 2012 · 62 citations · Full text

Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study

Massimo Offidani, Laura Corvatta, Laura Maracci et al. · Blood Cancer Journal · 2013 · 61 citations · Full text

Hematological Malignancy, Oncology, Health Sciences +14

PDEBENCH: An Extensive Benchmark for Scientific Machine Learning

Makoto Takamoto, Timothy Praditia, Raphael Leiteritz et al. · arXiv (Cornell University) · 2022 · 56 citations · Full text

Engineering, Machine Learning, Machine Learning Tool +19